肝脏相关出凝血功能障碍的机制与处理研究进展OA
Advances in the mechanisms and management of liver-re-lated coagulation and hemostatic disorders
肝脏相关出凝血功能障碍广泛见于肝硬化、肝癌、脓毒症相关肝损伤及肝切除术后,本质是促凝、抗凝与纤溶系统动态平衡的重构与失调,常表现为出血与血栓并存.传统凝血级联模型及常规检测关注凝血因子水平,难以全面反映肝内多细胞协同调控及动态止血状态.细胞凝血模型、免疫血栓形成及肝血窦多细胞互作研究结果显示,肝脏出凝血调控是由肝细胞、肝窦内皮细胞、Kupffer细胞以及炎症信号共同参与的动态网络.生理状态下,肝脏负责凝血物质合成、供给与清除;病理状态下,该网络出现肝血窦多细胞互作失衡及凝血因子合成-清除平衡异常.未来应从多细胞网络与动态系统角度重新认识肝脏出凝血调控机制,结合分子生物学技术与动态功能监测,构建更精准的评估与干预体系.
Liver-related coagulation dysfunction is commonly observed in liver cirrhosis,hepatocellular carcinoma,sepsis-associated liver injury,and post-hepatectomy states.The underlying pathology is a remodeling and dysregulation of the dynamic equilibrium among procoagulant,anticoagulant,and fibrinolytic systems,often manifesting as coexisting bleeding and thrombosis.The traditional coagulation cascade model and routine coagulation tests primarily focus on changes in coagulation factor levels,which fail to fully capture the multicellular synergistic regulation and dynamic hemostatic status within the hepatic microenvironment.Recent advances in the cell-based coagulation model,immunothrombosis theory,and hepatic sinusoidal biology multicellular interaction research have revealed that liver hemostasis regulation is a dynamic network involving hepatocytes,liver sinusoidal endothelial cells,Kupffer cells and inflammatory signals.Under physiological conditions,liver is responsible for the synthesis,supply,and clearance of coagulation factors.Under pathological conditions,this network undergoes remodeling,characterized by disrupted hepatic sinusoidal multicellular interactions and an imbalance in coagulation factor synthesis-clearance homeostasis.Further perspectives should reconceptualize liver hemostatic regulation from a multicellular network and dynamic systems viewpoint,integrating molecular biology techniques with dynamic functional monitoring to establish more precise assessment and intervention strategies.
张靖垚;番敏;曹茜蓉;张兴;任航雨;冷昊泽;刘昌
西安交通大学第一附属医院外科重症医学科,陕西西安 710061||外科重症及生命支持教育部重点实验室(西安交通大学),陕西西安 710061外科重症及生命支持教育部重点实验室(西安交通大学),陕西西安 710061||西安交通大学第二附属医院肝胆胰与肝移植外科,陕西西安 710004外科重症及生命支持教育部重点实验室(西安交通大学),陕西西安 710061||西安交通大学第二附属医院肝胆胰与肝移植外科,陕西西安 710004外科重症及生命支持教育部重点实验室(西安交通大学),陕西西安 710061||西安交通大学第二附属医院肝胆胰与肝移植外科,陕西西安 710004外科重症及生命支持教育部重点实验室(西安交通大学),陕西西安 710061||西安交通大学第二附属医院肝胆胰与肝移植外科,陕西西安 710004外科重症及生命支持教育部重点实验室(西安交通大学),陕西西安 710061||西安交通大学第二附属医院肝胆胰与肝移植外科,陕西西安 710004外科重症及生命支持教育部重点实验室(西安交通大学),陕西西安 710061||西安交通大学第二附属医院肝胆胰与肝移植外科,陕西西安 710004
医药卫生
肝疾病出凝血调控肝脏微环境再平衡止血临床管理
liver diseasescoagulation and hemostatic regulationhepatic microenvironmentrebalanced hemostasisclinical management
《中国实用外科杂志》 2026 (5)
682-685,696,5
四大慢病重大专项(No.2025ZD0551500)国家自然科学基金项目(No.82472191) Noncommunicable Chronic Diseases-National Science and Technology Major Project(No.2025ZD0551500)National Natural Science Foundation of China(No.82472191)
评论